1. Home
  2. DLPN vs INDP Comparison

DLPN vs INDP Comparison

Compare DLPN & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • INDP
  • Stock Information
  • Founded
  • DLPN 1996
  • INDP 2000
  • Country
  • DLPN United States
  • INDP United States
  • Employees
  • DLPN N/A
  • INDP N/A
  • Industry
  • DLPN Other Consumer Services
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • INDP Health Care
  • Exchange
  • DLPN Nasdaq
  • INDP Nasdaq
  • Market Cap
  • DLPN 12.3M
  • INDP 6.0M
  • IPO Year
  • DLPN N/A
  • INDP N/A
  • Fundamental
  • Price
  • DLPN $1.21
  • INDP $12.00
  • Analyst Decision
  • DLPN Strong Buy
  • INDP Strong Buy
  • Analyst Count
  • DLPN 1
  • INDP 2
  • Target Price
  • DLPN $5.00
  • INDP $238.00
  • AVG Volume (30 Days)
  • DLPN 28.3K
  • INDP 699.0K
  • Earning Date
  • DLPN 08-13-2025
  • INDP 08-11-2025
  • Dividend Yield
  • DLPN N/A
  • INDP N/A
  • EPS Growth
  • DLPN N/A
  • INDP N/A
  • EPS
  • DLPN N/A
  • INDP N/A
  • Revenue
  • DLPN $48,618,803.00
  • INDP N/A
  • Revenue This Year
  • DLPN $6.57
  • INDP N/A
  • Revenue Next Year
  • DLPN $18.10
  • INDP N/A
  • P/E Ratio
  • DLPN N/A
  • INDP N/A
  • Revenue Growth
  • DLPN 0.31
  • INDP N/A
  • 52 Week Low
  • DLPN $0.75
  • INDP $7.56
  • 52 Week High
  • DLPN $2.00
  • INDP $66.64
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 57.43
  • INDP 53.68
  • Support Level
  • DLPN $1.07
  • INDP $9.45
  • Resistance Level
  • DLPN $1.39
  • INDP $13.40
  • Average True Range (ATR)
  • DLPN 0.08
  • INDP 2.17
  • MACD
  • DLPN 0.01
  • INDP 0.20
  • Stochastic Oscillator
  • DLPN 56.25
  • INDP 29.39

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: